Environmental Working Group report on water is (typically) all wet

By ACSH Staff — Jan 06, 2011
Yesterday also saw the release of another “study” by the influential radical advocacy organization Environmental Working Group (EWG). EWG studied the origins, precise chemical contents and the labels of 173 brands of bottled water and then rated them. But what was the purpose of this? All of the water bottles contained...well, water. Some brands were somewhat more purified than others, and a few included flavorings of various sorts.

Yesterday also saw the release of another “study” by the influential radical advocacy organization Environmental Working Group (EWG). EWG studied the origins, precise chemical contents and the labels of 173 brands of bottled water and then rated them. But what was the purpose of this? All of the water bottles contained...well, water. Some brands were somewhat more purified than others, and a few included flavorings of various sorts.

Autism and vaccines: The supposed link was faked

By ACSH Staff — Jan 06, 2011
Yesterday the world learned that Dr. Andrew Wakefield is a fraud. British Medical Journal released the results of its investigation documenting the premeditation of Wakefield and his lawyer as co-conspirators who were attempting to extort compensation from vaccine makers. The investigators found that Dr. Wakefield concocted his findings to aid his attorney-partner’s lawsuits. He was paid $675,000 for this. The exposure of Dr.

Yesterday the world learned that Dr. Andrew Wakefield is a fraud. British Medical Journal released the results of its investigation documenting the premeditation of Wakefield and his lawyer as co-conspirators who were attempting to extort compensation from vaccine makers. The investigators found that Dr. Wakefield concocted his findings to aid his attorney-partner’s lawsuits. He was paid $675,000 for this. The exposure of Dr.

The flu season is among us, but there s still time to vaccinate!

By ACSH Staff — Jan 05, 2011
Late last week, the CDC reported that the flu season is picking up steam. The most recent data indicate a high level of influenza cases in Alabama, Georgia, Mississippi, Virginia, and New York City during the week of December 25. The flu is expected to peak in late January when children will be returning to school. However, the H1N1 swine flu is not this season’s dominant strain — so far, 70 percent of the circulating viruses are other influenza A strains, predominantly of the H3N2 strain.

Late last week, the CDC reported that the flu season is picking up steam. The most recent data indicate a high level of influenza cases in Alabama, Georgia, Mississippi, Virginia, and New York City during the week of December 25. The flu is expected to peak in late January when children will be returning to school. However, the H1N1 swine flu is not this season’s dominant strain — so far, 70 percent of the circulating viruses are other influenza A strains, predominantly of the H3N2 strain.

Road fatalities see economical drop

By ACSH Staff — Jan 05, 2011
The CDC gives us some good news, but it is a silver cloud with a black lining — road fatalities have experienced the largest reduction since World War II thanks in part to the poor economy. According to the report, U.S. road deaths dropped by 22 percent from from 43,510 to 33,963 between 2005 and 2009. The authors attribute this to “technological advances, primarily air bags, and the economic downturn.” The weak economy, they suggest, has reduced highway and rush hour traffic as local road traffic increased.

The CDC gives us some good news, but it is a silver cloud with a black lining — road fatalities have experienced the largest reduction since World War II thanks in part to the poor economy. According to the report, U.S. road deaths dropped by 22 percent from from 43,510 to 33,963 between 2005 and 2009. The authors attribute this to “technological advances, primarily air bags, and the economic downturn.” The weak economy, they suggest, has reduced highway and rush hour traffic as local road traffic increased.

Star Scientific s approach for FDA s OK flawed

By ACSH Staff — Jan 05, 2011
Yesterday brought news that smokeless tobacco manufacturer Star Scientific had issued a press release saying that they would ask the FDA to formally acknowledge that their new moist smokeless tobacco product, called Stonewall Moist-BDL, was 90-99 percent lower in carcinogens than those offered by their competitors.

Yesterday brought news that smokeless tobacco manufacturer Star Scientific had issued a press release saying that they would ask the FDA to formally acknowledge that their new moist smokeless tobacco product, called Stonewall Moist-BDL, was 90-99 percent lower in carcinogens than those offered by their competitors.

So thirty years ago!: CSPI pushes for synthetic food dye ban due to alleged hyperactivity link

By ACSH Staff — Jan 05, 2011
As the FDA prepares for a March hearing to assess whether synthetic food dyes cause hyperactivity in children, the Center for Science in the Public Interest (CSPI) is asking that they be banned altogether. Last year, the European Parliament banned synthetic food dyes — used to improve the appearance of packaged foods — in products geared towards babies and young children.

As the FDA prepares for a March hearing to assess whether synthetic food dyes cause hyperactivity in children, the Center for Science in the Public Interest (CSPI) is asking that they be banned altogether. Last year, the European Parliament banned synthetic food dyes — used to improve the appearance of packaged foods — in products geared towards babies and young children.

Vaccines to the rescue for chickenpox and pertussis

By ACSH Staff — Jan 04, 2011
Since routine chickenpox vaccinations were implemented in 1995, yearly rates of chickenpox infections in the U.S. decreased by 80 to 90 percent while the proportion of Americans hospitalized due to the infection has fallen by over two-thirds, a new study by the CDC finds. The vaccine prevented approximately 50,000 hospitalizations between 2000 and 2006. During this period, one in 100,000 Americans was hospitalized for chickenpox complications compared to four per every 100,000 people between 1988 and 1995.

Since routine chickenpox vaccinations were implemented in 1995, yearly rates of chickenpox infections in the U.S. decreased by 80 to 90 percent while the proportion of Americans hospitalized due to the infection has fallen by over two-thirds, a new study by the CDC finds. The vaccine prevented approximately 50,000 hospitalizations between 2000 and 2006. During this period, one in 100,000 Americans was hospitalized for chickenpox complications compared to four per every 100,000 people between 1988 and 1995.

Increased stroke risk from consumption of red meat just a bunch of baloney

By ACSH Staff — Jan 04, 2011
ACSH would like to induct a recent study seeking to link increased red meat consumption to a higher risk of stroke in women into our very own Data Dredging Hall of Fame/Shame. In an analysis of 34,670 Swedish women between the ages of 39 and 73, researchers found that those in the top tenth for red meat consumption — eating about 3.6 ounces daily — had a 42 percent higher chance of suffering from an ischemic stroke (from a blocked artery) than women who ate just under an ounce of red meat daily.

ACSH would like to induct a recent study seeking to link increased red meat consumption to a higher risk of stroke in women into our very own Data Dredging Hall of Fame/Shame. In an analysis of 34,670 Swedish women between the ages of 39 and 73, researchers found that those in the top tenth for red meat consumption — eating about 3.6 ounces daily — had a 42 percent higher chance of suffering from an ischemic stroke (from a blocked artery) than women who ate just under an ounce of red meat daily.

Potential of new cancer blood test: benefits may take years despite headlines

By ACSH Staff — Jan 04, 2011
Various news media outlets have trumpeted a new blood test that detects cancer cells, even though the diagnostic tool still remains in the infant stages of clinical application. Partnering with a Boston-based start-up company, health care giant Johnson & Johnson announced yesterday that it will work through its Veridex and Ortho Biotech Oncology units to bring the product to market.

Various news media outlets have trumpeted a new blood test that detects cancer cells, even though the diagnostic tool still remains in the infant stages of clinical application. Partnering with a Boston-based start-up company, health care giant Johnson & Johnson announced yesterday that it will work through its Veridex and Ortho Biotech Oncology units to bring the product to market.

New drug approvals still down

By ACSH Staff — Jan 04, 2011
Only 21 drugs were approved by the FDA in 2010. In 2009 and 2008, there were 25 and 24 drugs approved respectively, while 2007 marked an all-time low with only 18 new drugs approved. What are the reasons behind the decline in new drug approvals? ACSH’s Dr. Elizabeth Whelan believes that “excessively stringent safety standards at the FDA” are to blame.

Only 21 drugs were approved by the FDA in 2010. In 2009 and 2008, there were 25 and 24 drugs approved respectively, while 2007 marked an all-time low with only 18 new drugs approved.
What are the reasons behind the decline in new drug approvals? ACSH’s Dr. Elizabeth Whelan believes that “excessively stringent safety standards at the FDA” are to blame.